SEI Investments’s Enzo Biochem, Inc. ENZ Stock Holding History

SEI Investments’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-24,225	Closed	-$66K	–	2820
2019 Q1	$66K	Hold	24,225	–	–	﹤0.01%	2570
2018 Q4	$100K	Hold	24,225	–	–	﹤0.01%	2202
2018 Q3	$100K	Buy	24,225 +24,004	+10,862%	+$109K	﹤0.01%	2084
2018 Q2	$1K	Sell	221 -184	-45%	-$1.12K	﹤0.01%	3537
2018 Q1	$2K	Sell	405 -6,422	-94%	-$45.2K	﹤0.01%	3274
2017 Q4	$56K	Sell	6,827 -1,680	-20%	-$16K	﹤0.01%	2322
2017 Q3	$89K	Buy	8,507 +2,635	+45%	+$29.2K	﹤0.01%	2117
2017 Q2	$65K	Buy	5,872 +1,361	+30%	+$12.7K	﹤0.01%	2184
2017 Q1	$38K	Sell	4,511 -282	-6%	-$1.99K	﹤0.01%	2198
2016 Q4	$33K	Buy	4,793 +323	+7%	+$2.06K	﹤0.01%	2231
2016 Q3	$23K	Buy	4,470 +1,205	+37%	+$7.2K	﹤0.01%	2250
2016 Q2	$19K	Buy	3,265 +1,994	+157%	+$11.1K	﹤0.01%	2168
2016 Q1	$6K	Buy	1,271 +1,128	+789%	+$5.02K	﹤0.01%	2268
2015 Q4	$1K	Buy	+143	New	+$604	﹤0.01%	2465

Other funds holding ENZ

HFA

Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EGA

Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RAM

Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SEI Investments's ENZ Position: Q2 2019 in Review

SEI Investments sold out of Enzo Biochem, Inc. (ENZ) in Q2 2019, closing a stake of 24,225 shares — an estimated $66K sold.

SEI Investments first reported a position in ENZ in Q4 2015 and held it in 14 quarters. The position peaked at $100K in Q4 2018. 95 funds tracked by Wall St. Rank hold ENZ as of Q2 2019.

SEI Investments reported no remaining Enzo Biochem, Inc. position as of Q2 2019 after selling out during the quarter.
SEI Investments sold 24,225 Enzo Biochem, Inc. shares in Q2 2019, an estimated $66K.
SEI Investments first reported a position in Enzo Biochem, Inc. in Q4 2015 and held it in 14 quarters.
SEI Investments's Enzo Biochem, Inc. position peaked at $100K in Q4 2018.
95 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2019.

Based on SEI Investments's 13F filing for Q2 2019, filed 14 Aug 2019.